AMLX

Amylyx Pharmaceuticals

• Reuters·7h ago

  Amylyx to present at Needham Virtual Healthcare Conference

• TipRanks·8h ago

  Buy Rating on Amylyx: De-Risked Avexitide Phase III Study and Significant PBH Market Opportunity Support 2027 Launch Potential

• Simply Wall St·1d ago

  A Look At Amylyx Pharmaceuticals (AMLX) Valuation As Avexitide Hits A Key Phase 3 LUCIDITY Milestone

• Simply Wall St·04/01 17:21

  The Bull Case For Amylyx Pharmaceuticals (AMLX) Could Change Following LUCIDITY Trial Enrollment Milestone Completion

• Benzinga·04/01 12:02

  Beyond Meat Posts Downbeat Q4 Results, Joins RH, ORIC Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

• Simply Wall St·03/30 12:09

  A Look At Amylyx Pharmaceuticals (AMLX) Valuation After LUCIDITY Phase 3 Trial Reaches Full Enrollment

• TipRanks·03/28 14:36

  Amylyx Pharmaceuticals Inc (AMLX) Gets a Buy from LifeSci Capital

• TipRanks·03/25 16:50

  Analysts Are Bullish on These Healthcare Stocks: Repligen (RGEN), Amylyx Pharmaceuticals Inc (AMLX)

• Dow Jones·03/25 10:45

  Amylyx Pharmaceuticals Price Target Maintained With a $34.00/Share by HC Wainwright & Co.

• TipRanks·03/25 10:40

  Analysts Offer Insights on Healthcare Companies: Amylyx Pharmaceuticals Inc (AMLX), AbSci (ABSI) and Medtronic (MDT)

• Benzinga·03/25 10:35

  HC Wainwright & Co. Reiterates Buy on Amylyx Pharmaceuticals, Maintains $34 Price Target

• Simply Wall St·03/25 08:06

  The Bull Case For Amylyx Pharmaceuticals (AMLX) Could Change Following LUCIDITY Phase 3 Enrollment Completion

• TipRanks·03/24 11:28

  Amylyx Highlights Pipeline Progress in Updated Corporate Presentation

• Benzinga·03/24 11:19

  Amylyx Pharmaceuticals Says Last Participant Randomized And Dosed In Pivotal Phase 3 LUCIDITY Clinical Trial Of Avexitide

• TipRanks·03/24 11:05

  Amylyx completes enrollment in Phase 3 Lucidity trial of avexitide